Cefdinir-15N2,13C

Stability indicating assay procedure for method development and validation of cefdinir in its tablet doasage form by using RP-​HPLC
By Firdouse, Seema; Alam, Parwez; Mutalib, Abdul; Begum, Farhin; Sultana, Asra; Kulsum, Nishath
From World Journal of Pharmaceutical Research (2016), 5(1), 1342-1349
 
Stability-​indicating spectrophotometric methods for determination of cefdinir in pure form and pharmaceutical preparation
By Attia, Khalid A.; Nassar, Mohammed W.; Abou-Seada, Hamed M.; Emara, Mohamed Saleh
From International Journal of Pharmaceutical Sciences and Research (2014), 5(6), 2230-2237, 8
 
Isolation, structural elucidation and characterization of impurities in Cefdinir
By Rao, K. V. V. Prasada; Rani, A.; Reddy, A. V. Raghava; Bharathi, C. H.; Dandala, Ramesh; Naidu, A.
From Journal of Pharmaceutical and Biomedical Analysis (2007), 43(4), 1476-1482
 

Cefdinir-15N2,13C is chemically (6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo--5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid-15N2,13C . Cefdinir-15N2,13C is supplied with detailed characterization data compliant with regulatory guideline. Cefdinir-15N2,13C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefdinir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.